# Spesolimab in generalized pustular psoriasis complicated by acrodermatitis continua of Hallopeau: a case report and mechanistic insights

**Authors:** Xin-Yi Hou, Hai-Lu Xiao, Jing-Yu Wang, Jin Zhang, Bo Ren, Chu-chu Niu, Fei-Fei Liu, Bin Lu

PMC · DOI: 10.3389/fimmu.2025.1563553 · Frontiers in Immunology · 2025-05-15

## TL;DR

A 62-year-old woman with severe skin conditions improved significantly after treatment with spesolimab, with no adverse effects.

## Contribution

This case report demonstrates the effectiveness of spesolimab in treating generalized pustular psoriasis complicated by ACH.

## Key findings

- Spesolimab treatment led to significant improvement in the patient's GPP and ACH.
- No adverse reactions were observed during follow-up after spesolimab administration.

## Abstract

A 62-year-old Chinese woman presented to the hospital for help with generalized pustular psoriasis (GPP) and acrodermatitis continua of Hallopeau (ACH). While conventional treatments failed to achieve significant improvement, the patient received two doses of spesolimab, and the effect was remarkable. No adverse reactions were observed in the follow-up period.

## Linked entities

- **Diseases:** generalized pustular psoriasis (MONDO:0100491), acrodermatitis continua of Hallopeau (MONDO:0013626)

## Full-text entities

- **Diseases:** ACH (MESH:D011565)
- **Chemicals:** Spesolimab (MESH:C000712973)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12119614/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12119614/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12119614/full.md

---
Source: https://tomesphere.com/paper/PMC12119614